Cargando…

Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination

BACKGROUND: Data on the current burden of adenocarcinoma (ADC) and histology-specific human papillomavirus (HPV) type distribution are relevant to predict the future impact of prophylactic HPV vaccines. METHODS: We estimate the proportion of ADC in invasive cervical cancer, the global number of case...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pimenta, Jeanne M, Galindo, Claudia, Jenkins, David, Taylor, Sylvia M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871005/ https://www.ncbi.nlm.nih.gov/pubmed/24261839 http://dx.doi.org/10.1186/1471-2407-13-553

Ejemplares similares

Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK
por: Kohli, M, et al.
Publicado: (2007)

Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
por: Zhou, Xu, et al.
Publicado: (2020)

The Global Burden of Disease Study Estimates of Brazil’s Cervical Cancer Burden
por: Reis, Nathalia V. S., et al.
Publicado: (2020)

A Long Way: History of the Prophylactic Papillomavirus Vaccine
por: Müller, Martin, et al.
Publicado: (2007)

Estimates of the global burden of cervical cancer associated with HIV
por: Stelzle, Dominik, et al.
Publicado: (2020)

Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries
por: Natunen, Kari, et al.
Publicado: (2011)

Efficacy of prophylactic human papillomavirus vaccines on cervical cancer among the Asian population: A meta-analysis
por: Ren, Xinyu, et al.
Publicado: (2022)

Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study
por: Abbas, Kaja M, et al.
Publicado: (2020)

The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease
por: Garbuglia, Anna Rosa, et al.
Publicado: (2020)

Prophylactic Human Papillomavirus Vaccination: From the Origin to the Current State
por: Akhatova, Ayazhan, et al.
Publicado: (2022)

Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom
por: Van Effelterre, Thierry P, et al.
Publicado: (2015)

Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators
por: Spayne, Jacqueline, et al.
Publicado: (2021)

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer
por: Inturrisi, Federica, et al.
Publicado: (2020)

Global and Regional Estimates for Subtype-Specific Therapeutic and Prophylactic HIV-1 Vaccines: A Modeling Study
por: Elangovan, Ramyiadarsini, et al.
Publicado: (2021)

Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates
por: Mohan, Sakshi, et al.
Publicado: (2022)

Development of an in vitro carcinogenesis model of human papillomavirus‐induced cervical adenocarcinoma
por: Zhang, Mengzhu, et al.
Publicado: (2021)

Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines
por: Jagu, Subhashini, et al.
Publicado: (2009)

Detection of Human Papillomavirus in Chronic Cervicitis, Cervical Adenocarcinoma, Intraepithelial Neoplasia and Squamus Cell Carcinoma
por: Mirzaie-Kashani, Elahe, et al.
Publicado: (2014)

Estimating the Global Burden of Endemic Canine Rabies
por: Hampson, Katie, et al.
Publicado: (2015)

Global challenges of implementing human papillomavirus vaccines
por: Graham, Janice E, et al.
Publicado: (2011)

Human papillomavirus (HPV) screening and cervical cancer burden. A Brazilian perspective
por: Lorenzi, Adriana T., et al.
Publicado: (2015)

Potential Effects of Human Papillomavirus Type Substitution, Superinfection Exclusion and Latency on the Efficacy of the Current L1 Prophylactic Vaccines
por: Hampson, Ian N., et al.
Publicado: (2020)

Therapeutic Vaccines Against Human Papillomavirus and Cervical Cancer
por: Cid-Arregui, Angel
Publicado: (2009)

High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N’Djamena, Chad
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2019)

Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology
por: Hampson, Ian N.
Publicado: (2022)

Genetic alterations in juvenile cervical clear cell adenocarcinoma unrelated to human papillomavirus
por: Su, Yuehui, et al.
Publicado: (2023)

Estimates of the global burden of Japanese encephalitis and the impact of vaccination from 2000-2015
por: Quan, Tran Minh, et al.
Publicado: (2020)

Impact of cervical screening by human papillomavirus genotype: Population-based estimations
por: Wang, Jiangrong, et al.
Publicado: (2023)

The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature
por: Taylor, Sylvia, et al.
Publicado: (2016)

Reflections on the Global Burden of Disease 2010 Estimates
por: Byass, Peter, et al.
Publicado: (2013)

Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
por: Serrano, Beatriz, et al.
Publicado: (2012)

Global burden of childhood tuberculosis
por: Jenkins, Helen E.
Publicado: (2016)

Correction: Estimating the Global Burden of Endemic Canine Rabies
por: Hampson, Katie, et al.
Publicado: (2015)

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial
Publicado: (2010)

Association of Maternal Cervical Disease With Human Papillomavirus Vaccination Among Offspring
por: Worsham, Christopher M., et al.
Publicado: (2021)

Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe
por: Chin’ombe, Nyasha, et al.
Publicado: (2014)

Can quadrivalent human papillomavirus prophylactic vaccine be an effective alternative for the therapeutic management of genital warts? an exploratory study
por: Choi, Hoon
Publicado: (2019)

Cervical Human Papillomavirus Screening among Older Women
por: Grainge, Matthew J., et al.
Publicado: (2005)

Results of cytology and high-risk human papillomavirus testing in females with cervical adenocarcinoma in situ
por: ANDERSSON, SONIA, et al.
Publicado: (2013)

The Global Burden of Meningitis in Children: Challenges with Interpreting Global Health Estimates
por: Wright, Claire, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5im9hd461clvb5t98bqfbgm7t5